BioSpace News Archive

Biotech Bay

Pharma Companies Can Cut Clinical Trial Randomization Set Up 89 Percent with Oracle

The complexity of clinical research and development has increased exponentially, putting a strain on outdated systems used to support the business processes required to conduct a clinical trial.

December 18, 2018
·
2 min read
Business

Smartlink Health Solutions Welcomes Mark Dunnagan as VP of Health Informatics

Smartlink Health Solutions, a pioneer in bidirectional health data exchange via front-end integration, announced today that Mark Dunnagan has joined its leadership team as Vice President of Health Informatics.

December 18, 2018
·
2 min read
Business

Second Heart Assist Announces Wireless Power Patent License Agreement with Vascor for Powering Aorta Positioned Circulatory Assist Device

Licensing agreement includes broad coverage for more than 35 issued patent claims for improving wireless power transmission for implantable circulatory assist pumps within the lower aorta.

December 18, 2018
·
5 min read
Pharm Country

Progenra Inc. Receives Therapeutic Pipeline Award from The Michael J. Fox Foundation for Parkinson’s Research and Drug Development

Funding will support Progenra’s development of small molecules for treatment of Parkinson’s Disease

December 18, 2018
·
2 min read
Policy

CTI BioPharma Provides Program Update Following Regulatory Feedback from the U.S. FDA on Pacritinib Development

CTI receives input on key elements of new Phase 3 trial design for patients with myelofibrosis and severe thrombocytopenia

December 18, 2018
·
3 min read
Business

MedTrust Expands Service to Jacksonville, FL

Move to Florida market marks medical transport company’s latest growth milestone

December 18, 2018
·
2 min read
BioForest

New Study Finds Orphan Drug Exclusivity Working As Intended, On-Market Orphan Drug Prices Rise Slower than Common Drugs

A new report commissioned by the National Organization for Rare Disorders (NORD) and published today by the IQVIA Institute, demonstrates that the seven-year market exclusivity granted to drugs designated under the Orphan Drug Act of 1983 for rare diseases is working as intended.

December 18, 2018
·
3 min read
Business

DarwinHealth and Xiamen Encheng Group Co., Ltd., Enter Into Strategic Licensing Partnership to Market DarwinOncoTarget™ and DarwinOncoTreat™ Tests in Greater China

The Xiamen Encheng Group Co., Ltd., a pharmaceutical services and precision medicine-focused company located in Xiamen City, Fujian Province, China, announced today that it has entered into a strategic partnership with DarwinHealth, Inc, a New York City biotechnology company.

December 18, 2018
·
5 min read
Business

Intarcia Provides 2019 Corporate Update

Intarcia Therapeutics Inc. today provided an update on the company’s progress in 2018 and trajectory for advancement in 2019.

December 18, 2018
·
5 min read
Biotech Beach

Ligand Introduces 2019 Financial Outlook and Raises 2018 Financial Guidance

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) introduces its financial outlook for 2019. Ligand expects revenue in 2019 to be at least $212 million, with up to an additional $40 million of potential milestone and license payments.

December 18, 2018
·
5 min read